MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 40 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,603 | -60.5% | 19,600 | 0.0% | 0.01% | -53.3% |
| Q2 2023 | $29,400 | -12.8% | 19,600 | 0.0% | 0.02% | -6.2% |
| Q1 2023 | $33,712 | +146473.9% | 19,600 | 0.0% | 0.02% | +23.1% |
| Q4 2022 | $23 | -100.0% | 19,600 | 0.0% | 0.01% | -59.4% |
| Q3 2022 | $51,000 | +18.6% | 19,600 | 0.0% | 0.03% | +10.3% |
| Q2 2022 | $43,000 | -52.7% | 19,600 | 0.0% | 0.03% | -65.9% |
| Q1 2022 | $91,000 | -23.5% | 19,600 | 0.0% | 0.08% | +10.4% |
| Q4 2021 | $119,000 | +46.9% | 19,600 | +74.4% | 0.08% | +28.3% |
| Q3 2021 | $81,000 | +14.1% | 11,240 | 0.0% | 0.06% | +27.7% |
| Q2 2021 | $71,000 | – | 11,240 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |